glp-1 medications approved for diabetes and weight loss 2025 Therapy Part 1: Setting Realistic Expectations – Sarah Hormachea Chart: 1 in 8 Americans

Some of the more serious health complications include gastroparesis, intestinal blockages, aspiration under general anesthesia, psychiatric harm, and vision loss

The pen cap must be replaced after each use

After the final dose, semaglutide can remain in the body for approximately 57 weeks, with conservative clinical guidance often citing up to 8 weeks for near-complete washout

These are not medication-specific principles

It is interesting to note that the positive effect of tirzepatide on body weight is associated with a significant improvement in quality of life and physical performance [50] and is independent of sex [51], baseline body mass index (BMI) [52] and potential side effects, predominantly gastrointestinal [53]